Research

Industry-sponsored cancer clinical trials are more likely to focus on single-agent drug therapies than trials sponsored by the federal government, according to a study published Aug. 20 in JAMA Oncology. Researchers from Seattle-based Fred Hutch Cancer Center and New York…

New Orleans-based Ochsner Health launched a partnership with Paradigm Health to integrate clinical trial recruitment within the health system’s electronic health record.  Paradigm’s platform uses AI to analyze patient data and continuously identify patients who meet clinical trial eligibility requirements,…

The American College of Obstetricians and Gynecologists has released updated guidelines supporting fallopian tube removal to reduce ovarian cancer risk.  The updated guidance was published Aug. 20 in Obstetrics & Gynecology.  The move comes after a study found fallopian tube…

Cancer patients who live in counties with higher levels of medical debt were more likely to be diagnosed at a later stage and had worse survival outcomes, according to a study published Aug. 18 in the Journal of the National…

Adding chemotherapy to immunotherapy before surgery reduced tumor size more effectively than immunotherapy alone in patients with head and neck cancers, according to a study published Aug. 13 in JAMA Otolaryngology-Head & Neck Surgery. Researchers at New York City-based Mount…

Patient wait times to receive first-course therapy after a cancer diagnosis grew by almost two weeks between 2012 and 2023, according to a study published Aug. 12 in JAMA Surgery.  For the study, researchers from the University of California Los…

A nationwide, evidence-based tobacco treatment program for cancer patients and survivors in the U.S. would save $12.32 billion in healthcare costs over 10 years, according to a study published July 14 in JCO Oncology Practice. Led by researchers from Houston-based…

Johns Hopkins Kimmel Cancer Center liver cancer experts co-authored a new treatment framework for hepatocellular carcinoma called BEACON-HCC, published Aug. 7 in the journal Hepatology. The framework was developed with 16 other cancer centers under HCC-LIVE, a consortium of North…

Genetic testing added to routine newborn screening could identify babies at increased risk of developing cancer before symptoms appear, according to a study being published Aug. 12 in Nature Communications. The study was led by Lisa Diller, MD, vice chair…

A blood test detected the majority of colorectal cancers and precancerous lesions in a study published Aug. 10 in The Lancet Gastroenterology & Hepatology. The study was led by Ajay Goel, PhD, chair of the department of molecular diagnostics and…